Allan Camaisa - CEO and Chairman of the Board, Director, 10%+ Owner at Calidi Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO and Chairman of the Board, Director, 10%+ Owner
Stock Symbol
CLDI, CLDI-WT on NYSE
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Allan Camaisa since 9/18/2023

Holdings reported by Allan Camaisa for Calidi Biotherapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 6.1M $11M $1.80 Sep 12, 2023 By Jamir Trust
Common Stock 2.8M $5.04M $1.80 Sep 12, 2023 By AJC Capital LLC
Common Stock 65.6K $118K $1.80 Sep 12, 2023 Direct
Non-Qualified Stock Options (right to buy) 100K Dec 21, 2023 Direct Common stock
Stock Options (right to buy) 40K Jun 17, 2024 Direct Common stock $40K

Transactions reported by Allan Camaisa for Calidi Biotherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.